KOREAN
Company
Business
R & D
Investors
Company Overview
Welcome Message
Vision & Mission
History
C.I
Careers
Contact Us
Umbilical Cord Blood-derived Stem Cell
Stem Cell Therapy
Stem Cell Conditioned Media
Stem Cell Culture Media
Cell Freezing and Thawing Platform
CDMO
Health & Beauty(H&B) Business
Core Technology
Global R&D Center
Stem Cell GMP Center
Pipeline
Notice
IR
PR
Investors
Notice
IR
Disclosure Information
Stock Information
IR Resource Center
IR Letter & FAQ
PR
Press Release
PR Resource Center
IR Letter & FAQ
Investors
IR
IR Letter & FAQ
[IR FAQ] 아토피 피부염 치료제 (Furestem-AD 주) 투약을 촉진하기 위하여 강스템바이오텍은 어떤노력을 하고 있나요?
2022/12/23 10:04:20
Q&A 리포트_2.jpg
(133.34 KB)
목록으로
[IR레터] 2022년 연간(외부감사전 자료기준) IR레터
[IR FAQ] 아토피 피부염 치료제 (Furestem-AD 주)의 현재 투약현황과 완료시점을 알려주세요!
About Us
Stock Information
Careers
Contact Us
Global R&D Center
Stem Cell GMP Center
Pipeline
TOP
pr : ir_faq : view : : /pr/ir_faq/view